Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Zelira Therapeutics ( (AU:ZLD) ) has shared an announcement.
Zelira Therapeutics Limited has issued a prospectus for an offer of up to 1,000 shares at $0.50 each, aiming to raise $500 before expenses. This transaction-specific prospectus is designed to remove secondary trading restrictions on shares issued under a facility agreement with Securities Vault Pty Ltd, and the offer closes on April 4, 2025. The shares are considered speculative, and the prospectus is not for distribution in the United States.
More about Zelira Therapeutics
YTD Price Performance: -22.34%
Average Trading Volume: 380
Technical Sentiment Signal: Buy
Current Market Cap: $3.43M
Find detailed analytics on ZLD stock on TipRanks’ Stock Analysis page.